Bombay Oxygen Investments Ltd (BOMOXY-B1) is currently trading at 17,500.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Bombay Oxygen Investment Limited, formerly Bombay Oxygen Corporation, operates as a Non-Banking Financial Company (NBFC) registered with the Reserve Bank of India. It primarily earns revenue from substantial financial investments in shares, mutual funds, and other securities. The company, originally known for manufacturing industrial gases, ceased its production of industrial gases in August 2019, transitioning to focus on financial investments. The company has had historical collaborations with General Electrodes and Equipments, Germany, and Messer AGS GmbH for engineering services. Bombay Oxygen Investment Limited's subsidiaries, Savita Pharmaceuticals and Raptakos Brett & Company, once engaged in pharmaceuticals, ceased as subsidiaries following disinvestment. Major shifts include commissions of its tonnage and liquefier plants and historical developments like designing cryogenic liquid oxygen pumps.

Over the past 52 weeks, Bombay Oxygen Investments Ltd has traded between a low of ₹16,000.00 and a high of ₹25,500.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Bombay Oxygen Investments Ltd has a market capitalization of approximately 262.50. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Bombay Oxygen Investments Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 1381.58 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 262.50 Cr, Bombay Oxygen Investments Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Bombay Oxygen Investments Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Bombay Oxygen Investments Ltd is 1381.58. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Bombay Oxygen Investments reported a net loss of ₹324.06 crore for FY26, compared with a net profit of ₹1,750.59 crore in FY25.